Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Learn how a yield-focused dividend ETF can fit into a retirement plan, delivering income while maintaining simplicity and liquidity.
19,425 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
A large insider purchase by Conagra's CEO has investors buzzing. Learn what insider buying signals really mean, how t...
Ripple has spent close to $3 billion on acquisitions since 2023 to build out institutional rails. The moves aim to em...
Cracking the code on a potential real estate rebound? play means stacking three strategic bets: affordable debt, grow...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Rate expanded its team by hiring seven former Movement Mortgage loan officers in December 2025, underscoring a broade...
You’ve bought a few rental properties, but the real work starts now. This guide delivers a step-by-step plan to optim...
As Appian reports Q4 2025 results, investors reassess growth, profitability, and long-term value. This guide breaks d...
A fast-growing company with a software-led model and global expansion is catching investor attention. This growth sto...
Target’s stock has surged 33% from October lows, prompting renewed questions about a possible buyout. This report ana...
CoreWeave’s latest trading session highlighted the tension between high-growth AI clouds and the realities of funding...
Microsoft trades at a decade-low multiple as AI tools expand and Copilot adoption lags. Investors weigh the AI upside...